Treffer 1 - 4 von 4 für Suche 'Grunenberger, Audrey', Suchdauer: 0,41s Treffer weiter einschränken
  1. 1
    Enhanced CRISPR-Cas9 RNA system delivery using cell penetrating peptides-based nanoparticles for efficient in vitro and in vivo applications

    Enhanced CRISPR-Cas9 RNA system delivery using cell penetrating peptides-based nanoparticles for efficient in vitro and in vivo applications von Guzman Gonzalez, Veronica, Grunenberger, Audrey, Nicoud, Olivier, Czuba, Elodie, Vollaire, Julien, Josserand, Véronique, Le Guével, Xavier, Desai, Nail, Coll, Jean-Luc, Divita, Gilles, Faure, Virginie

    Veröffentlicht in Journal of controlled release

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Abstract C102: mRNA-mediated restoration of BRCA-1 tumor suppressor function prevents tumor growth and reverses resistance to PARP inhibitors in triple-negative breast cancers

    Abstract C102: mRNA-mediated restoration of BRCA-1 tumor suppressor function prevents tumor growth and reverses resistance to PARP inhibitors in triple-negative breast cancers von DIVITA, Gilles, Grunenberger, Audrey, Cabrera, Léa, Durany, Nathalie, Boularache, Khadidja, Josserand, Veronique, Desai, Neil

    Veröffentlicht in Molecular cancer therapeutics

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Abstract 550: p53 rescue of tumor suppressor function with ADGN-531 causes tumor regression both as single agent and in combination with PARPi and KRASG12Cinhibitors

    Abstract 550: p53 rescue of tumor suppressor function with ADGN-531 causes tumor regression both as single agent and in combination with PARPi and KRASG12Cinhibitors von Divita, Gilles, Grunenberger, Audrey, Czuba, Elodie, Boularache, Khadidja, Guidetti, Melanie, Josserand, Veronique, Desai, Neil

    Veröffentlicht in Cancer research (Chicago, Ill.)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Abstract 1717: KRAS mutant gene editing prevents tumor growth in vivo and overcomes acquired resistance to KRASG12C inhibitor

    Abstract 1717: KRAS mutant gene editing prevents tumor growth in vivo and overcomes acquired resistance to KRASG12C inhibitor von Divita, Gilles, Guzman-Gonzales, Veronica, Grunenberger, Audrey, Czuba, Elodie, Guidetti, Melanie, Josserand, Veronique, Desai, Neil

    Veröffentlicht in Cancer research (Chicago, Ill.)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: